(Q52787532)
Statements
The Novel Cyclin-Dependent Kinase 4/6 Inhibitor Ribociclib (LEE011) Alone and in Dual-Targeting Approaches Demonstrates Antitumoral Efficacy in Neuroendocrine Tumors in vitro. (English)
1 reference
Elke Tatjana Aristizabal Prada
1 reference
Svenja Nölting
1 reference
Gerald Spoettl
1 reference
Julian Maurer
1 reference
Christoph Joseph Auernhammer
1 reference
23 February 2017
1 reference